1,550
Views
34
CrossRef citations to date
0
Altmetric
Special Focus Commentary

Dengue human infection model

Re-establishing a tool for understanding dengue immunology and advancing vaccine development

Pages 1587-1590 | Received 20 Feb 2013, Accepted 04 Mar 2013, Published online: 06 Mar 2013

References

  • Simmons JS, St John JH, Reynolds FHK. Experimental studies of dengue. Philipp J Sci 1931; 44:1 - 252
  • Guzman MG, Halstead SB, Artsob H, Buchy P, Farrar J, Gubler DJ, et al. Dengue: a continuing global threat. Nat Rev Microbiol 2010; 8:Suppl S7 - 16; http://dx.doi.org/10.1038/nrmicro2460; PMID: 21079655
  • Beatty ME, Stone A, Fitzsimons DW, Hanna JN, Lam SK, Vong S, et al, Asia-Pacific and Americas Dengue Prevention Boards Surveillance Working Group. Best practices in dengue surveillance: a report from the Asia-Pacific and Americas Dengue Prevention Boards. PLoS Negl Trop Dis 2010; 4:e890; http://dx.doi.org/10.1371/journal.pntd.0000890; PMID: 21103381
  • Centers for Disease Control and Prevention (CDC). Travel-associated Dengue surveillance - United States, 2006-2008. MMWR Morb Mortal Wkly Rep 2010; 59:715 - 9; PMID: 20559202
  • Chen LH, Wilson ME. Dengue and chikungunya in travelers: recent updates. Curr Opin Infect Dis 2012; 25:523 - 9; http://dx.doi.org/10.1097/QCO.0b013e328356ffd5; PMID: 22825287
  • Gibbons RV, Streitz M, Babina T, Fried JR. Dengue and US military operations from the Spanish-American War through today. Emerg Infect Dis 2012; 18:623 - 30; http://dx.doi.org/10.3201/eid1804.110134; PMID: 22469290
  • Hynes NA. Dengue: A reemerging concern for travelers. Cleve Clin J Med 2012; 79:474 - 82; http://dx.doi.org/10.3949/ccjm.79a.11048; PMID: 22751631
  • de Laval F, Plumet S, Simon F, Deparis X, Leparc-Goffart I. Dengue surveillance among French military in Africa. Emerg Infect Dis 2012; 18:342 - 3; http://dx.doi.org/10.3201/eid1802.111333; PMID: 22305127
  • Anna MM, Escobar JD, Chapman AS. Reported vectorborne and zoonotic diseases, U.S. Air Force, 2000-2011. MSMR 2012; 19:11 - 2, discussion 12-4; PMID: 23121007
  • Trofa AF, DeFraites RF, Smoak BL, Kanesa-thasan N, King AD, Burrous JM, et al. Dengue fever in US military personnel in Haiti. JAMA 1997; 277:1546 - 8; http://dx.doi.org/10.1001/jama.1997.03540430058033; PMID: 9153369
  • Sharp TW, Wallace MR, Hayes CG, Sanchez JL, DeFraites RF, Arthur RR, et al. Dengue fever in U.S. troops during Operation Restore Hope, Somalia, 1992-1993. Am J Trop Med Hyg 1995; 53:89 - 94; PMID: 7625541
  • Hayes CG, O’Rourke TF, Fogelman V, Leavengood DD, Crow G, Albersmeyer MM. Dengue fever in American military personnel in the Philippines: clinical observations on hospitalized patients during a 1984 epidemic. Southeast Asian J Trop Med Public Health 1989; 20:1 - 8; PMID: 2772694
  • Deller JJ Jr., Russell PK. An analysis of fevers of unknown origin in American soldiers in Vietnam. Ann Intern Med 1967; 66:1129 - 43; PMID: 5338939
  • Halasa YA, Shepard DS, Zeng W. Economic cost of dengue in Puerto Rico. Am J Trop Med Hyg 2012; 86:745 - 52; http://dx.doi.org/10.4269/ajtmh.2012.11-0784; PMID: 22556069
  • Gubler DJ. The economic burden of dengue. Am J Trop Med Hyg 2012; 86:743 - 4; http://dx.doi.org/10.4269/ajtmh.2012.12-0157; PMID: 22556068
  • Torres JR, Castro J. The health and economic impact of dengue in Latin America. Cadernos de saude publica / Ministerio da Saude, Fundacao Oswaldo Cruz. Escola Nacional de Saude Publica 2007; 23:Suppl 1 S23 - 31
  • Anderson KB, Chunsuttiwat S, Nisalak A, Mammen MP, Libraty DH, Rothman AL, et al. Burden of symptomatic dengue infection in children at primary school in Thailand: a prospective study. Lancet 2007; 369:1452 - 9; http://dx.doi.org/10.1016/S0140-6736(07)60671-0; PMID: 17467515
  • Gubler DJ. Epidemic dengue/dengue hemorrhagic fever as a public health, social and economic problem in the 21st century. Trends Microbiol 2002; 10:100 - 3; http://dx.doi.org/10.1016/S0966-842X(01)02288-0; PMID: 11827812
  • Sabchareon A, Wallace D, Sirivichayakul C, Limkittikul K, Chanthavanich P, Suvannadabba S, et al. Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trial. Lancet 2012; 380:1559 - 67; http://dx.doi.org/10.1016/S0140-6736(12)61428-7; PMID: 22975340
  • Endy TP, Chunsuttiwat S, Nisalak A, Libraty DH, Green S, Rothman AL, et al. Epidemiology of inapparent and symptomatic acute dengue virus infection: a prospective study of primary school children in Kamphaeng Phet, Thailand. Am J Epidemiol 2002; 156:40 - 51; http://dx.doi.org/10.1093/aje/kwf005; PMID: 12076887
  • Endy TP, Anderson KB, Nisalak A, Yoon IK, Green S, Rothman AL, et al. Determinants of inapparent and symptomatic dengue infection in a prospective study of primary school children in Kamphaeng Phet, Thailand. PLoS Negl Trop Dis 2011; 5:e975; http://dx.doi.org/10.1371/journal.pntd.0000975; PMID: 21390158
  • Jarman RG, Holmes EC, Rodpradit P, Klungthong C, Gibbons RV, Nisalak A, et al. Microevolution of Dengue viruses circulating among primary school children in Kamphaeng Phet, Thailand. J Virol 2008; 82:5494 - 500; http://dx.doi.org/10.1128/JVI.02728-07; PMID: 18367520
  • Rico-Hesse R. Microevolution and virulence of dengue viruses. Adv Virus Res 2003; 59:315 - 41; http://dx.doi.org/10.1016/S0065-3527(03)59009-1; PMID: 14696333
  • Cassetti MC, Durbin A, Harris E, Rico-Hesse R, Roehrig J, Rothman A, et al. Report of an NIAID workshop on dengue animal models. Vaccine 2010; 28:4229 - 34; http://dx.doi.org/10.1016/j.vaccine.2010.04.045; PMID: 20434551
  • Zompi S, Harris E. Animal models of dengue virus infection. Viruses 2012; 4:62 - 82; http://dx.doi.org/10.3390/v4010062; PMID: 22355452
  • Sun W, Endy TP, Nisalak A, Gettayacamin M, Eckels KH, Putnak R, et al. Tetravalent live-attenuated dengue virus vaccination protects rhesus monkeys against viremia from virulent dengue virus challenge. American Society for Virology Annual Meeting. Fort Collins, CO, 2000.
  • Osorio JE, Brewoo JN, Silengo SJ, Arguello J, Moldovan IR, Tary-Lehmann M, et al. Efficacy of a tetravalent chimeric dengue vaccine (DENVax) in Cynomolgus macaques. Am J Trop Med Hyg 2011; 84:978 - 87; http://dx.doi.org/10.4269/ajtmh.2011.10-0592; PMID: 21633037
  • Sauerwein RW, Roestenberg M, Moorthy VS. Experimental human challenge infections can accelerate clinical malaria vaccine development. Nat Rev Immunol 2011; 11:57 - 64; http://dx.doi.org/10.1038/nri2902; PMID: 21179119
  • Mallia P, Message SD, Gielen V, Contoli M, Gray K, Kebadze T, et al. Experimental rhinovirus infection as a human model of chronic obstructive pulmonary disease exacerbation. Am J Respir Crit Care Med 2011; 183:734 - 42; http://dx.doi.org/10.1164/rccm.201006-0833OC; PMID: 20889904
  • Janowicz DM, Ofner S, Katz BP, Spinola SM. Experimental infection of human volunteers with Haemophilus ducreyi: fifteen years of clinical data and experience. J Infect Dis 2009; 199:1671 - 9; http://dx.doi.org/10.1086/598966; PMID: 19432549
  • Atmar RL, Opekun AR, Gilger MA, Estes MK, Crawford SE, Neill FH, et al. Norwalk virus shedding after experimental human infection. Emerg Infect Dis 2008; 14:1553 - 7; http://dx.doi.org/10.3201/eid1410.080117; PMID: 18826818
  • Landmann JK, Prociv P. Experimental human infection with the dog hookworm, Ancylostoma caninum. Med J Aust 2003; 178:69 - 71; PMID: 12526725
  • Freedman DO. Experimental infection of human subject with Strongyloides species. Rev Infect Dis 1991; 13:1221 - 6; http://dx.doi.org/10.1093/clinids/13.6.1221; PMID: 1775856
  • Miller FG, Grady C. The ethical challenge of infection-inducing challenge experiments. Clin Infect Dis 2001; 33:1028 - 33; http://dx.doi.org/10.1086/322664; PMID: 11528576
  • Hope T, McMillan J. Challenge studies of human volunteers: ethical issues. J Med Ethics 2004; 30:110 - 6; http://dx.doi.org/10.1136/jme.2003.004440; PMID: 14872087
  • Killingley B, Enstone J, Booy R, Hayward A, Oxford J, Ferguson N, et al, influenza transmission strategy development group. Potential role of human challenge studies for investigation of influenza transmission. Lancet Infect Dis 2011; 11:879 - 86; http://dx.doi.org/10.1016/S1473-3099(11)70142-6; PMID: 21798808
  • Graham H. Dengue: a study of its mode of propagation and pathology. MedRecNew york 1902; 61:204-7.
  • Graham H. The dengue: a study of its pathology and mode of propagation. J Trop Med 1903;
  • Ashburn PM, Craig CF. Experimental investigations regarding the etiology of dengue fever. J Infect Dis 1907; 4:440 - 75; http://dx.doi.org/10.1093/infdis/4.3.440; PMID: 15116315
  • Siler JF, Hall MW, Hitchens AP. Dengue: Its history, epidemilogy, mechanism of transmission, etiology, clinical manifestations, immunity, and prevention. Philipp J Sci 1926; 29:1 - 304
  • Cleland JB, Bradley B, Macdonald W. Further experiments in the etiology of dengue fever. J Hyg (Lond) 1919; 18:217 - 54; http://dx.doi.org/10.1017/S0022172400007476; PMID: 20474685
  • Sawada T, Sato H, Sai S. On the experimental dengue infection in man. Nippon Igaku 1943; 3325:529 - 31
  • Sabin AB. Research on dengue during World War II. Am J Trop Med Hyg 1952; 1:30 - 50; PMID: 14903434
  • Sabin AB, Schlesinger RW. Production of immunity to dengue with virus modified by propagation in mice. Science 1945; 101:640 - 2; http://dx.doi.org/10.1126/science.101.2634.640; PMID: 17844088
  • McCoy OR, Sabin AB. Dengue. In: Coates JB, Hoff EC, Hoff PM, eds. Preventive Medicine in World War II Communicable Diseases Arthropodborne Diseases Other Than Malaria. Washington, DC: Office of the Surgeon General, 1946:29-62.
  • Hotta S. Experimental studies on dengue. I. Isolation, identification and modification of the virus. J Infect Dis 1952; 90:1 - 9; http://dx.doi.org/10.1093/infdis/90.1.1; PMID: 14888958
  • Yaoi H. A summary of our studies on dengue. Yokohama Med Bull 1958; 9:1 - 20; PMID: 13558217
  • Sun W, Eckels KH, Putnak JR, Lyons AG, Thomas SJ, Vaughn DW, et al. Experimental dengue virus challenge of human subjects previously vaccinated with live attenuated tetravalent dengue vaccines. J Infect Dis 2013; 207:700 - 8; http://dx.doi.org/10.1093/infdis/jis744; PMID: 23225894
  • Gunther VJ, Putnak R, Eckels KH, Mammen MP, Scherer JM, Lyons A, et al. A human challenge model for dengue infection reveals a possible protective role for sustained interferon gamma levels during the acute phase of illness. Vaccine 2011; 29:3895 - 904; http://dx.doi.org/10.1016/j.vaccine.2011.03.038; PMID: 21443963
  • Statler J, Mammen M, Lyons A, Sun W. Sonographic findings of healthy volunteers infected with dengue virus. J Clin Ultrasound 2008; 36:413 - 7; http://dx.doi.org/10.1002/jcu.20476; PMID: 18446859
  • Edelman R, Hombach J. “Guidelines for the clinical evaluation of dengue vaccines in endemic areas”: summary of a World Health Organization Technical Consultation. Vaccine 2008; 26:4113 - 9; http://dx.doi.org/10.1016/j.vaccine.2008.05.058; PMID: 18597906
  • Watanaveeradej V, Simasathien S, Nisalak A, Endy TP, Jarman RG, Innis BL, et al. Safety and immunogenicity of a tetravalent live-attenuated dengue vaccine in flavivirus-naive infants. Am J Trop Med Hyg 2011; 85:341 - 51; http://dx.doi.org/10.4269/ajtmh.2011.10-0501; PMID: 21813857
  • Simasathien S, Thomas SJ, Watanaveeradej V, Nisalak A, Barberousse C, Innis BL, et al. Safety and immunogenicity of a tetravalent live-attenuated dengue vaccine in flavivirus naive children. Am J Trop Med Hyg 2008; 78:426 - 33; PMID: 18337339

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.